NLRP3-IN-65

NLRP3-IN-65 (compound 41) is a selective and potent small molecule inhibitor targeting the NLRP3 inflammasome. It has demonstrated efficacy in reducing IL-1β secretion in cellular assays and shows potential for research in inflammatory and autoimmune disease models, both in vitro and in vivo.